Croconazole, an antimycotic agent, demonstrates dose-dependent inhibition of neutrophil 5-lipoxygenase (5-LOX), with IC50 values of 7.8 µM for LTB4 and 5-HETE synthesis. This activity supports its research use in studying eicosanoid pathways and inflammation in both cellular and biochemical assay systems.